Effects of OROS methylphenidate (OROS MPH) treatment in children and adolescents with ADHD, mental retardation and epilepsy

被引:1
|
作者
Kesic, A. [1 ]
Lakic, A. [1 ]
Dronjak, D. [2 ]
Stupar, D. [1 ]
机构
[1] Sch Med, Inst Neurol & Psychiat Children & Adolescents, Belgrade, Serbia
[2] Gen Hosp, Krusevac, Serbia
关键词
D O I
10.1016/S0924-977X(12)70659-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S420 / S421
页数:2
相关论文
共 50 条
  • [1] The incidence of personality disorder in adults with ADHD, and the effects on response to treatment with OROS methylphenidate (OROS MPH)
    Casciol, Carissa
    Sassoon, Rachel E.
    Carroll-Sharpe, Abigail
    Essick, Gregory K.
    Baranek, Grace T.
    BIOLOGICAL PSYCHIATRY, 2008, 63 (07) : 245S - 245S
  • [2] Assessing Personality Disorder in Adults With ADHD, and its Effects on Response to Treatment with OROS® Methylphenidate (OROS® MPH)
    Robison, Reid
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Gale, Phillip
    Williams, Erika D.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 632 - 632
  • [3] Tolerability of OROS® MPH for treatment of ADHD plus epilepsy
    Gonzalez-Heydrich, Joseph M.
    Whitney, Jane E.
    Hsin, Olivia
    Rao, Sneha N.
    Mrakotsky, Christine
    Waber, Deborah P.
    MacMillan, Carlene M.
    Torres, Alcy R.
    Pravdova, Iva J.
    DeMaso, David R.
    Bourgeois, Blaise F. D.
    Biederman, Joseph J.
    ANNALS OF NEUROLOGY, 2006, 60 : S47 - S48
  • [4] Effects of OROS® methylphenidate (MPH) treatment on behavior and performance in children with ADHD with and without comorbid learning disability
    Starr, H. Lynn
    Armstrong, Robert
    Damaraju, C., V
    Ascher, Steve
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S126 - S126
  • [5] The Impact of Age on Treatment Response With OROS® Methylphenidate (MPH) in Adults With ADHD
    Starr, Harriet L.
    Goodman, David W.
    Damaraju, Chandrasekhar Rao V.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 637 - 637
  • [6] Combined OROS MPH and atomoxetine in ADHD treatment in children
    Wilens, Timothy
    Hammerness, Paul
    Spencer, Thomas J.
    Whitley, Julia
    Traina, Stephanie
    Santry, Alison
    Biederman, Joseph
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 660 - 661
  • [7] Treatment of adolescent ADHD with OROS® methylphenidate
    McBurnett, K
    PEDIATRIC RESEARCH, 2003, 53 (04) : 555A - 555A
  • [8] OROS MPH treatment effects between girls and boys with ADHD
    Starr, Harriette L.
    Zhang, Huabin
    Kemner, Jason E.
    Cooper, Kimberly M.
    JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS, 2006, 27 (05): : 442 - 442
  • [9] Personality Disorder Assessment in Adult ADHD Utilizing Subjects Enrolled in a Clinical Trial of OROS® Methylphenidate (OROS® MPH)
    Williams, Erika
    Reimherr, Frederick W.
    Marchant, Barrie K.
    Strong, Robert E.
    Halls, Corinne
    Soni, Poonam
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2008, 18 (06) : 635 - 636
  • [10] Time Course of Treatment Effect of OROS® Methylphenidate in Children With ADHD
    Armstrong, Robert B.
    Damaraju, C. V.
    Ascher, Steve
    Schwarzman, Lesley
    O'Neill, James
    Starr, H. Lynn
    JOURNAL OF ATTENTION DISORDERS, 2012, 16 (08) : 697 - 705